Some scholars have also found that[30] lncRNA FAM66C regulates downstream target genes to drive intrahepatic cholangiocarcinoma progression and glycolysis activity through sponge action of miR-23b-3p, suggesting that FAM66C may be a potential target for the treatment of ICC. Here, FAM66C is linked to intrahepatic cholangiocarcinoma.